Kommuniké från extra bolagsstämma i Ortoma AB

Published December 18, 2015

Se nyheten

 Den 17 december 2015 hölls bolagstämma i Ortoma AB. Vid stämman fattades bland annat följande beslut:

Val av styrelsesuppleant
Daniel Andersson valdes som styrelsesuppleant

Val av revisor
KPMG valdes som bolagets revisionsbolag. KPMG har utsett Mikael Ekberg som huvudansvarig revisor.

Bemyndigande om nyemission
Stämman gav styrelsen ett bemyndigande fram till nästa årsstämma att besluta om nyemission med företrädesrätt för bolagets aktieägare av sammanlagt 500 000 aktier i bolaget.

Göteborg den 17 december 2015
Ortoma AB

För ytterligare information vänligen kontakta:
Matts Andersson, VD
Telefon 070-821 70 51
E-post: [email protected]

About Ortoma AB (publ)
Ortoma AB develops surgical systems for the planning and positioning of implants in hip, knee and spinal surgery. The purpose of the company’s surgical system, Ortoma Treatment Solution™ (OTS) is to enable surgeons to accurately measure and plan 3D surgery for the placement of joint implants, and during surgery, to optimally position the implant in the patient. Ortoma’s surgical system is aimed at providing better patient outcomes, fewer complications and less follow-up surgeries – and thus better long-term survival rates for implants. OTS is a system that is easily integrated into the processes and routines currently used in surgery, thereby increasing efficiency. Globally, more than 7.5 million orthopedic procedures are performed each year where OTS could be used in hip, knee and spinal surgery. In Sweden, around 42,000 surgical procedures were performed last year, involving hip, knee or spinal surgery. Ortoma’s B shares are listed on Nasdaq First North Growth Market Stockholm.